JPMorgan Doesn't See A Competing Bid For St. Jude Medical, Downgrades To Neutral
April 29, 2016 at 11:58 AM EDT
On April 28, Abbott Laboratories (NYSE: ABT) announced the acquisition of St. Jude Medical, Inc. (NYSE: STJ) for $82.50 per ...